Kendra J. Bjoraker is known nationally and internationally for her clinical and research work in neurocognitive and neurobehavioral outcomes in children with various neurological conditions. EXPERTISE RARE GENETIC DISEASES Lysosomal diseases Alpha-Mannosidosis Aspartylglucosaminuria Batten disease (Neuronal Ceroid Lipofuscinoses) Beta-Mannosidosis Cholesteryl Ester storage disease Cystinosis Danon disease Fabry disease Barber disease Fucosidosis Galactosialidosis Gaucher disease Gangliosidosis Krabbe disease Metachromatic leukodystrophy Lysosomal diseases (Cont) Mucopolysaccharidoses disorders MPS I – Hurler syndrome MPS II – Hunter syndrome MPS III – Sanfilippo (A, B, C, D) MPS IV – Morquio syndrome (A & B) MPS VI – Maroteaux-Lamy syndrome MPS VII – Sly syndromeMucolipidosis Type I (Sialidosis) Mucolipidosis Type II (I-Cell disease) Mucolipidosis Type III (Pseudo-Hurler polydystrophy) Mucolipidosis Type IV Multiple Sulfatase Deficiency Niemann-Pick Types A & B Pompe disease (Glycogen Storage disease) Sandhoff disease Schindler disease Tay-Sachs disease Wolman disease Peroxisomal diseases Adrenokeukodystrophy (ALD) Phenylketonuria (PKU) Neurodevelopmental disorders Neuromuscular disorders Duchenne muscular dystrophy (DMD) Becker muscular dystrophy (BMD) Spinal muscular atrophy (SMA) Limb-girdle muscular dystrophy Pompe disease Charcot-Marie-Tooth disease (CMT)/Hereditary Motor Sensory Neuropathy Congenital muscular dystrophy Facioscapulohumeral dystrophy Friedreich’s Ataxia Myotonic dystrophy Nonketotic Hyperglycinemia (NKH) Urea Cycle Disorders